Delivery Order SPE2DB22D3501-SPE2DB25FXK80
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,758.31 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.19 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging of 5s. This competitive award, executed on April 23, 2025, with an ultimate completion date of April 24, 2025, reflects a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,224.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Aprepitant 130mg/18ml (a chemotherapy-related nausea and vomiting preventative medication). This non-set-aside delivery order is expected to reach completion by September 8, 2025, with fulfillment taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5-count) on July 24, 2025, with a contract ceiling value of $1,698.52 and ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,225.52 to AmerisourceBergen Drug Corp for Emporphed 50 mg/10 mL vials on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Medical Supply Chain for the supply of Fosphenytoin 500 mg PE/10 mL (10 mL vials) with a ceiling value of $1,189.39. This firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion by September 10, 2025. The award represents a routine pharmaceutical procurement fulfilling federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $98,352.08 to AmerisourceBergen Drug Corp on April 28, 2025, with an ultimate completion date of April 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The vendor, headquartered...
- The Defense Logistics Agency awarded a Delivery Order (4569006087) valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with a completion date of August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. The company serves as a critical vendor...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK80Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,582.92 to AmerisourceBergen Drug Corp for Fosaprepitant 150 mg vials, with an ultimate completion date of September 22, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to the prime contractor, which is headquartered in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Fosaprepitant, an antiemetic medication commonly used in cancer treatment protocols, aligns with the company's established role in supplying specialized pharmaceuticals to the Defense Health Agency and other government healthcare systems through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/19/25 |